Pulmonology Consultant caught up with Danny Eckert, PhD, after his SLEEP 2019 session.
Danny Eckert: Recent advances in knowledge of the causes of OSA that indicate at least one-third of people with OSA are “light sleepers” or have a “low respiratory arousal threshold” phenotype. This has led our group and others to conduct a series of studies to determine the potential therapeutic benefit of certain hypnotics for these specific people with OSA, as well as hypnotics’ effects on upper airway muscle activity and next-day consequences from a safety perspective.
